Neuroscience
Available at BMC Neurology
Proceedings of the 2009 Drug Discovery for Neurodegeneration Conference
Proceedings from Drug Discovery for Neurodegeneration Conference
Washington, DC, USA. 2–3 February 2009
Edited by Diana W Shineman and Howard M Fillit
BMC Neurology
Contents of Volume 9 Suppl 1
Click here for open access to contents of this issue
- Clinical Trials: Evp-6124 Phase 2b Clinical Trial In Schizophrenia
From Drug Discovery & Development: Positive Study Results for Schizophrenia Drug Drug Discovery & Development December 05, 2011 "EnVivo Pharmaceuticals announced the analysis of a completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable...
- Neurodegenerative Disease Drug Discovery: Ucsf And Genentech
From Fierce Biotech: UCSF enters drug discovery agreement with Genentech Posted February 19, 2010 "The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover...
- Fda: Datscan: A Radiopharmaceutical And Parkinson Disease
Following up on a posting earlier this week: From a General Electrics press release 11 August 2009 FDA ADVISORY COMMITTEE RECOMMENDS DaTSCAN™ (Ioflupane I 123 Injection) PRINCETON, NJ--GE Healthcare announced today that the Peripheral and Central...
- Upcoming Event: Los Angeles, 31 July - 03 August 2005
From the University of Southern California website: US-Japan Conference on Drug Development and Rational Drug Design - Pathways of Innovative Drug Targeting: From a Molecular to Clinical Perspective This conference represents the 3rd Conference on Drug...
- Upcoming Event: Boston, 20-21 September 2005
A conference on ion channels in disease biology and ion channel targets in drug discovery will be held in Waltham (Boston region), Massachusetts on the 20th and 21st of September 2005. Further information about the meeting can be found at the following...
Neuroscience
Drug Development in Neurodegenerative Diseases
Available at BMC Neurology
Proceedings of the 2009 Drug Discovery for Neurodegeneration Conference
Proceedings from Drug Discovery for Neurodegeneration Conference
Washington, DC, USA. 2–3 February 2009
Edited by Diana W Shineman and Howard M Fillit
BMC Neurology
Contents of Volume 9 Suppl 1
Click here for open access to contents of this issue
- Clinical Trials: Evp-6124 Phase 2b Clinical Trial In Schizophrenia
From Drug Discovery & Development: Positive Study Results for Schizophrenia Drug Drug Discovery & Development December 05, 2011 "EnVivo Pharmaceuticals announced the analysis of a completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable...
- Neurodegenerative Disease Drug Discovery: Ucsf And Genentech
From Fierce Biotech: UCSF enters drug discovery agreement with Genentech Posted February 19, 2010 "The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover...
- Fda: Datscan: A Radiopharmaceutical And Parkinson Disease
Following up on a posting earlier this week: From a General Electrics press release 11 August 2009 FDA ADVISORY COMMITTEE RECOMMENDS DaTSCAN™ (Ioflupane I 123 Injection) PRINCETON, NJ--GE Healthcare announced today that the Peripheral and Central...
- Upcoming Event: Los Angeles, 31 July - 03 August 2005
From the University of Southern California website: US-Japan Conference on Drug Development and Rational Drug Design - Pathways of Innovative Drug Targeting: From a Molecular to Clinical Perspective This conference represents the 3rd Conference on Drug...
- Upcoming Event: Boston, 20-21 September 2005
A conference on ion channels in disease biology and ion channel targets in drug discovery will be held in Waltham (Boston region), Massachusetts on the 20th and 21st of September 2005. Further information about the meeting can be found at the following...